Neoadjuvant Radiotherapy for High-risk UTUC

Clinical trial NCT06472752 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06472752
Sponsor: Peking University First Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Urothelial Carcinoma of the Renal Pelvis and Ureter

Start date: 2024-06-30
Primary completion: 2025-06-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.